Monte Carlo-based QSAR modeling of dimeric pyridinium compounds and drug design of new potent acetylcholine esterase inhibitors for potential therapy of myasthenia gravis
- 7 June 2016
- journal article
- research article
- Published by Springer Nature in Structural Chemistry
- Vol. 27 (5) , 1511-1519
Abstract
No abstract availableKeywords
Funding Information
- Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (43012)
This publication has 40 references indexed in Scilit:
- SMILES-based QSAR model for arylpiperazines as high-affinity 5-HT1A receptor ligands using CORALEuropean Journal of Pharmaceutical Sciences, 2013
- CORAL: Quantitative structure–activity relationship models for estimating toxicity of organic compounds in ratsJournal of Computational Chemistry, 2011
- CORAL: Building up the model for bioconcentration factor and defining it’s applicability domainEuropean Journal of Medicinal Chemistry, 2011
- Myasthenia gravisOrphanet Journal of Rare Diseases, 2007
- SMILES as an alternative to the graph in QSAR modelling of bee toxicityComputational Biology and Chemistry, 2007
- Myasthenia gravis: past, present, and futureJournal of Clinical Investigation, 2006
- Semi-empirical topological index: a tool for QSPR/QSAR studiesJournal of Molecular Modeling, 2005
- A New Descriptor for Structure−Property and Structure−Activity CorrelationsJournal of Chemical Information and Computer Sciences, 2001
- Myasthenia GravisNew England Journal of Medicine, 1994
- SMILES. 3. DEPICT. Graphical depiction of chemical structuresJournal of Chemical Information and Computer Sciences, 1990